Archives
-
Atrial Natriuretic Peptide in Cell Assays
2026-09-14
This scenario-based guide explains how to incorporate Atrial Natriuretic Peptide (ANP) (C49H84N20O15S), rat (SKU A1009) into cell viability, proliferation, and cytotoxicity workflows. It focuses on controls, formulation, handling, interpretation, and evidence-based product selection for cardiovascular and translational research.
-
Necrostatin-1: A Translational Probe for Necroptosis
2026-09-13
Necrostatin-1 is more than a reagent for blocking regulated necrotic death: it is a mechanistic probe for separating RIP1-dependent necroptosis from ferroptosis, autophagy, and apoptosis in complex disease models. This thought-leadership article examines how a RIP1 kinase inhibitor can strengthen cell-death studies inspired by the 2023 3-bromopyruvate/cetuximab resistance study, while defining practical assay parameters, translational opportunities in tissue injury and acute kidney injury research, and the limitations that must be addressed before pathway modulation can inform therapeutic strategy.
-
Small-Molecule Control of Pancreatic Ductal Organoids
2026-09-12
Liao and colleagues developed a small-molecule culture strategy that improves the initiation and long-term expansion of pancreatic ductal organoids while retaining heterogeneous ductal and acinar populations. The work provides a practical organoid platform for pancreatic disease modeling, drug screening, and investigation of ductal–acinar plasticity.
-
GCLC Truncation and Delayed Age-Related Cataract
2026-09-11
Wei et al. identify age-related truncation of the γ-glutamylcysteine ligase catalytic subunit (GCLC) at Asp499 as a mechanism that may drive the decline of lens glutathione and accelerate cataract formation. In a D499E knock-in mouse model, preventing this truncation preserved the glutathione defense system and substantially delayed age-related cataract, providing a mechanistic basis for prevention-oriented research.
-
Ginsenoside Rg6 Reverses Cisplatin Resistance in EOC
2026-09-11
A 2025 study links cisplatin resistance in epithelial ovarian cancer cells to altered fucosylation and identifies the GRB2–ERK1/2–mTOR axis as a mechanistic connection to autophagy. Its findings suggest that ginsenoside Rg6 may improve cisplatin activity by promoting autophagy, restoring CTR1-associated drug uptake, and reducing protein fucosylation, although validation beyond cell models is still needed.
-
In Vitro Drug Response Metrics in Cancer
2026-09-10
Hannah Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these readouts capture different contributions from proliferative arrest and cell death. The framework supports more informative, time-aware evaluation of anticancer responses and helps researchers avoid treating a single viability value as a complete measure of drug efficacy.
-
EZ Cap™ Cas9 mRNA (m1Ψ) Workflow
2026-09-10
Build a transient CRISPR-Cas9 workflow around Cap1-capped, m1Ψ-modified Cas9 mRNA for flexible genome editing in mammalian cells. This guide connects practical dosing, RNA handling, specificity testing, and nuclear-export biology to help researchers distinguish delivery problems from true editing limitations.
-
IPR-803 and Small-Molecule uPAR–uPA Inhibition
2026-09-09
The reference study established IPR-803 as a tractable small-molecule urokinase receptor inhibitor that disrupts the uPAR–uPA protein–protein interaction. By combining direct binding assays, cellular invasion models, pharmacokinetics, and a breast cancer metastasis model, it connected biochemical activity with an in vivo anti-metastatic outcome while also identifying important development limitations.
-
Cyanine 3 Tyramide for Cross-Species Brain Maps
2026-09-09
A thought-leadership guide to using Cyanine 3 Tyramide as a fluorescent dye for biomedical research, with mechanistic context for Tyramide Signal Amplification and a translational framework inspired by comparative claustrum gene-expression research.
-
MOG (35-55): A Mechanistic EAE Research Guide
2026-09-08
MOG (35-55) is a powerful myelin oligodendrocyte glycoprotein peptide for modeling EAE and multiple sclerosis biology. This guide connects peptide-driven disease induction with the STAT1/STAT2 interferon mechanism and translates that insight into practical assay decisions.
-
Alda 1: Reliable ALDH2 Assay Workflows
2026-09-08
This scenario-based guide explains how Alda 1 (SKU B5508) can strengthen ALDH2-focused viability, proliferation, cytotoxicity, and cardiac ischemia research workflows. It covers variant-aware experimental design, solvent and storage controls, interpretation of proliferation data, and practical criteria for selecting a reliable research reagent.
-
Necrostatin-1 RIP1 Kinase Inhibitor Workflows
2026-09-07
Build cleaner necroptosis experiments with Necrostatin-1, a selective RIP1 kinase inhibitor for pathway dissection, inflammatory injury models, and host–microbe studies. This guide connects practical dosing, assay controls, and troubleshooting to emerging evidence on bacterial T3SS-driven colitis.
-
Separating Growth Arrest from Cell Death in Cancer Assays
2026-09-07
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent dimensions of anticancer drug response. This framework helps researchers design assays and interpret dose–response data without treating reduced metabolic or proliferative output as direct evidence of cell killing.
-
Losartan Workflows for AT1 Signaling Research
2026-09-05
Losartan provides a practical, receptor-proximal way to dissect angiotensin II signaling, vascular smooth muscle behavior, and blood-pressure biology. This workflow-focused guide connects assay design, compound handling, quantitative readouts, and carefully bounded insights from diabetic nephropathy research.
-
2-Thio-dCTP Workflow for DNA Assays
2026-09-04
2-Thio-dCTP enables controlled incorporation of a sulfur-modified cytidine into DNA, supporting polymerase profiling, site-specific DNA modification, and DNA–protein interaction studies. This practical guide connects reagent handling with assay design inspired by new findings on SCP4, H3T3 dephosphorylation, and chromosome stability.